The NHS today becomes the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia, with almost 18,000 people in England now being eligible. 

In England, there are around 17,000 people living with sickle cell disorder, with 250 new cases a year. 

Read more – NHSE (22/1/24)